ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A.
Iyer P, et al. Among authors: dutt a, dutt s.
Int J Cancer. 2019 Apr 15;144(8):2008-2019. doi: 10.1002/ijc.31916. Epub 2018 Dec 8.
Int J Cancer. 2019.
Free PMC article.